Anxiety and depression status prior to radioactive iodine therapy among differentiated thyroid cancer patients during the COVID‑19 pandemic

Support Care Cancer. 2022 Dec;30(12):10169-10177. doi: 10.1007/s00520-022-07422-7. Epub 2022 Nov 3.

Abstract

Objection: The psychological health of thyroid cancer patients cannot be ignored; however, few studies have been conducted on the psychological status and influencing factors of thyroid cancer patients before radioactive iodine (RAI) therapy. The aim of this study was to investigate the incidence and risk factors for anxiety and depression in thyroid cancer patients prior to RAI therapy.

Methods: Clinical data were collected from patients with differentiated thyroid cancer (DTC) patients preparing for RAI therapy. Anxiety and depression were measured before RAI therapy using the Generalized Anxiety Disorder Questionnaire (GAD-7) and Patient Health Questionnaire (PHQ-9). We used the chi-square test and logistic regression analysis to identify independent risk factors for anxiety and depression.

Results: A total of 112 patients with thyroid cancer were included. Of these, 72.32% (n = 81) were female, with a mean age of 41.50 years. Anxiety and depression were reported by 46 (41.08%) and 38 (33.93%) patients, respectively. Based on the chi-square test and univariate logistic regression analysis, being female and having ever-experienced RAI therapy were significant risk factors for anxiety and depression among DTCs prior to RAI therapy. On multivariable analysis, the results of model 2 which included age, sex, education level, and ever suffering radioactive iodine therapy showed that being female was markedly associated with anxiety and depression in these patients, while having ever undergone RAI therapy was significantly related to anxiety but not depression.

Conclusions: The incidence of anxiety and depression among patients with DTC prior to RAI therapy were 41.08% and 33.93%, respectively. Being female and having ever experienced RAI therapy significantly influenced anxiety and depression. Based on these findings, anxiety and depression assessment should be an important part of pre-RAI therapy in patients with DTC, and appropriate psychological nursing intervention can be carried out for key patients.

Keywords: Anxiety; COVID-19; Depression; Differentiated thyroid cancer; Radioactive iodine therapy.

MeSH terms

  • Adenocarcinoma*
  • Adult
  • Anxiety / epidemiology
  • Anxiety / etiology
  • Anxiety Disorders / epidemiology
  • COVID-19* / epidemiology
  • Female
  • Humans
  • Iodine Radioisotopes / adverse effects
  • Male
  • Pandemics
  • Thyroid Neoplasms* / epidemiology
  • Thyroid Neoplasms* / radiotherapy
  • Thyroidectomy

Substances

  • Iodine Radioisotopes